In another clinical study by Zhang et al., eight children with an average age of 12 years, suffering from R/R AML, received anti-CLL-1 CAR-T cells with endoplasmic domain 4-1BB. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.